2026 NPPES data Pharmacist NPI 1912409111 PHARMD
Verify on CMS →

LARA AGOPIAN, PHARMD

Pharmacist in BURBANK, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
388
Medicare Part D claims · 222 beneficiaries · Pharmacist avg: 135
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: LARA AGOPIAN, PHARMD is a Pharmacist ([object Object]) practicing in BURBANK, California with a Medicare Part D prescribing footprint of 388 claims across 222 beneficiaries — 5% brand-name prescribing .

What stands out: LARA AGOPIAN, PHARMD filed 388 Medicare Part D claims in 2023 across BURBANK, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

LARA AGOPIAN, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/02/2018

NPI 1912409111

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

388 187% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Pharmacist share within California

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LARA AGOPIAN, PHARMD is a Pharmacist provider practicing in BURBANK, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1912409111. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LARA AGOPIAN, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 303 S GLENOAKS BLVD STE 16, BURBANK, CA, 91502, with a listed phone of (818) 846-9011. NPI 1912409111 was issued on 03/02/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AGOPIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 388 prescription claims written by this provider, covering 222 Medicare beneficiaries and totaling roughly $35K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

303 S GLENOAKS BLVD STE 16
BURBANK, CA 91502

Provider Details

NPI 1912409111
Specialty Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 03/02/2018

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LARA AGOPIAN, PHARMD. To verify LARA AGOPIAN, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

LARA AGOPIAN, PHARMD — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 388 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

388
Total Claims
$35K
Total Drug Cost
222
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
388
Total Day Supply
11,553
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$2K
Generic Drug Cost
$33K

Patient Demographics

Average Patient Age
63.7 years
Avg HCC Risk Score
1.83
Gender Split
61% female / 39% male
Age Distribution
<65: 109, 65-74: 85, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Naloxone Hcl
388

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How LARA AGOPIAN, PHARMD fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

LARA AGOPIAN, PHARMD's 388 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as AGOPIAN.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LARA AGOPIAN, PHARMD's specialty?
LARA AGOPIAN, PHARMD specializes in Pharmacist and practices in BURBANK, California. Credentials: PHARMD.
How much does LARA AGOPIAN, PHARMD prescribe under Medicare Part D?
In 2023, LARA AGOPIAN, PHARMD wrote 388 Medicare Part D claims totaling $35K in drug costs for 222 beneficiaries.
Where is LARA AGOPIAN, PHARMD located?
LARA AGOPIAN, PHARMD is located at 303 S GLENOAKS BLVD STE 16, BURBANK, CA, 91502. Phone: (818) 846-9011.
What is LARA AGOPIAN, PHARMD's NPI number?
LARA AGOPIAN, PHARMD's National Provider Identifier (NPI) is 1912409111, issued on 03/02/2018.
Does LARA AGOPIAN, PHARMD prescribe more brand-name or generic drugs?
LARA AGOPIAN, PHARMD's prescribing is 5% brand-name and 95% generic drugs by claim count, with $2K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does LARA AGOPIAN, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, LARA AGOPIAN, PHARMD's most frequently prescribed drugs include Naloxone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LARA AGOPIAN, PHARMD accept Medicare?
LARA AGOPIAN, PHARMD appears in CMS Medicare data with 388 Part D claims and 222 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LARA AGOPIAN, PHARMD's credentials?
LARA AGOPIAN, PHARMD's NPI is 1912409111 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology